|

Brentuximab vedotin (Adcetris) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Nivolumab

Pipeline

Phase 2: 1

Top Sponsors

  • New York Medical College1

Indications

  • Anaplastic Large Cell Lymphoma, ALK-Positive1
  • Cancer1

Valhalla, New York1 trial

Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL

New York Medical College

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.